IONIS Pharmaceuticals Inc. is 10% Owner at AKCEA THERAPEUTICS, INC. (AKCA). They have made 3 open-market trades across 1 company since 2017, most recently 2020-10-10.
3 open-market purchases totalling $1.2B since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AKCA | 98,322,397 | $1.8B |
Shares reported on the most recent Form 4, priced at the 2020-10-14 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.